|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||131.04 - 131.04|
|52-week range||71.51 - 151.96|
|Beta (5Y monthly)||0.60|
|PE ratio (TTM)||27.41|
|Forward dividend & yield||0.81 (0.62%)|
|Ex-dividend date||01 Jul 2021|
|1y target est||N/A|
LUXEMBOURG, October 19, 2021--Regulatory News: Easy, reliable, high quality and cost-effective testing for SARS-CoV-2 (COVID-19) is critical to help reopen and keep open many aspects of society and business sectors worldwide. Eurofins (Paris:ERF) is working with schools and education authorities to design and implement cost-effective solutions to test this important part of our community regularly and reliably.
LUXEMBOURG, October 05, 2021--Regulatory News: Eurofins Scientific SE (Paris:ERF):
LEE’S SUMMIT, Mo., October 01, 2021--The United States District Court for District of Delaware has ruled that the patent asserted in CareDx’s patent infringement case against Eurofins Viracor is invalid. Eurofins Viracor is very pleased that the Court has agreed with its arguments and issued judgment in Eurofins Viracor’s favor in this challenge to Eurofins’ critically important diagnostic tools to manage organ rejection risk.